Sagent Pharmaceuticals, Inc. Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sagent Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sagent Pharmaceuticals, Inc. for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Option Exercise | A | 27.15 | 18,468 | 501,406 | 18,468 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Grant | A | 0.00 | 9,945 | 0 | 686,014 | 676.1 K to 686 K (+1.47 %) |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | HUSSEY JAMES M | President | Option Exercise | A | 27.15 | 9,234 | 250,703 | 9,234 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | HUSSEY JAMES M | President | Grant | A | 0.00 | 4,972 | 0 | 11,058 | 6.1 K to 11.1 K (+81.70 %) |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | A | 27.15 | 8,208 | 222,847 | 8,208 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Grant | A | 0.00 | 4,420 | 0 | 19,655 | 15.2 K to 19.7 K (+29.01 %) |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | A | 27.15 | 8,208 | 222,847 | 8,208 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Grant | A | 0.00 | 4,420 | 0 | 48,243 | 43.8 K to 48.2 K (+10.09 %) |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Option Exercise | A | 27.15 | 6,840 | 185,706 | 6,840 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Grant | A | 0.00 | 3,683 | 0 | 27,902 | 24.2 K to 27.9 K (+15.21 %) |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Option Exercise | A | 27.15 | 8,208 | 222,847 | 8,208 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Grant | A | 0.00 | 4,420 | 0 | 36,996 | 32.6 K to 37 K (+13.57 %) |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Option Exercise | A | 27.15 | 6,840 | 185,706 | 6,840 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | A | 0.00 | 1,841 | 0 | 1,841 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | A | 0.00 | 1,841 | 0 | 1,841 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | A | 0.00 | 1,841 | 0 | 1,841 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 0.00 | 1,841 | 0 | 1,841 | |
| Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | A | 0.00 | 1,841 | 0 | 1,841 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | M | 0.00 | 567 | 0 | 567 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | M | 0.00 | 760 | 0 | 1,520 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Buy | M | 0.00 | 567 | 0 | 4,150 | 3.6 K to 4.2 K (+15.82 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Buy | M | 0.00 | 760 | 0 | 3,583 | 2.8 K to 3.6 K (+26.92 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Payment of Exercise | F | 28.50 | 293 | 8,351 | 24,219 | 24.5 K to 24.2 K (-1.20 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Payment of Exercise | F | 28.50 | 449 | 12,797 | 24,512 | 25 K to 24.5 K (-1.80 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 567 | 0 | 567 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 760 | 0 | 1,520 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 567 | 0 | 9,253 | 8.7 K to 9.3 K (+6.53 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 760 | 0 | 8,686 | 7.9 K to 8.7 K (+9.59 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | M | 0.00 | 567 | 0 | 567 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | M | 0.00 | 760 | 0 | 1,520 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Buy | M | 0.00 | 567 | 0 | 4,150 | 3.6 K to 4.2 K (+15.82 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Buy | M | 0.00 | 760 | 0 | 3,583 | 2.8 K to 3.6 K (+26.92 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | M | 0.00 | 567 | 0 | 567 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | M | 0.00 | 760 | 0 | 1,520 | |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Buy | M | 0.00 | 567 | 0 | 36,909 | 36.3 K to 36.9 K (+1.56 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Buy | M | 0.00 | 760 | 0 | 36,342 | 35.6 K to 36.3 K (+2.14 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 28.50 | 429 | 12,227 | 43,823 | 44.3 K to 43.8 K (-0.97 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 28.50 | 637 | 18,155 | 44,252 | 44.9 K to 44.3 K (-1.42 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 28.50 | 336 | 9,576 | 32,576 | 32.9 K to 32.6 K (-1.02 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 28.50 | 610 | 17,385 | 32,912 | 33.5 K to 32.9 K (-1.82 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 28.50 | 395 | 11,258 | 15,235 | 15.6 K to 15.2 K (-2.53 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 28.50 | 586 | 16,701 | 15,630 | 16.2 K to 15.6 K (-3.61 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Payment of Exercise | F | 28.50 | 918 | 26,163 | 676,069 | 677 K to 676.1 K (-0.14 %) |
| Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Payment of Exercise | F | 28.50 | 1,227 | 34,970 | 676,987 | 678.2 K to 677 K (-0.18 %) |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | M | 0.00 | 930 | 0 | 2,790 | |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Buy | M | 0.00 | 930 | 0 | 2,823 | 1.9 K to 2.8 K (+49.13 %) |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Payment of Exercise | F | 27.22 | 452 | 12,303 | 24,961 | 25.4 K to 25 K (-1.78 %) |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | M | 0.00 | 930 | 0 | 2,790 | |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Buy | M | 0.00 | 930 | 0 | 1,521 | 591 to 1.5 K (+157.36 %) |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 930 | 0 | 2,790 | |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 930 | 0 | 7,926 | 7 K to 7.9 K (+13.29 %) |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | HUSSEY JAMES M | President | Payment of Exercise | F | 27.22 | 610 | 16,604 | 6,086 | 6.7 K to 6.1 K (-9.11 %) |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | M | 0.00 | 930 | 0 | 2,790 | |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Buy | M | 0.00 | 930 | 0 | 2,823 | 1.9 K to 2.8 K (+49.13 %) |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | M | 0.00 | 930 | 0 | 2,790 | |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Buy | M | 0.00 | 930 | 0 | 35,582 | 34.7 K to 35.6 K (+2.68 %) |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 27.22 | 581 | 15,815 | 44,889 | 45.5 K to 44.9 K (-1.28 %) |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 27.22 | 452 | 12,303 | 33,522 | 34 K to 33.5 K (-1.33 %) |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 27.22 | 542 | 14,753 | 16,216 | 16.8 K to 16.2 K (-3.23 %) |
| Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Payment of Exercise | F | 27.22 | 1,053 | 28,663 | 678,214 | 679.3 K to 678.2 K (-0.16 %) |